We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFE icon
1351
New Fortress Energy
NFE
$87.1M
– –
-8,301
Closed -$254K
NPO icon
1352
Enpro
NPO
$6.53B
– –
-1,272
Closed -$215K
NVCR icon
1353
NovoCure
NVCR
$2.09B
– –
-13,623
Closed -$213K
OGN icon
1354
Organon & Co
OGN
$3.61B
– –
-13,683
Closed -$257K
OMF icon
1355
OneMain Financial
OMF
$7.35B
– –
-4,104
Closed -$210K
PENN icon
1356
PENN Entertainment
PENN
$2.33B
– –
-17,749
Closed -$323K
PSN icon
1357
Parsons
PSN
$5.26B
– –
-2,508
Closed -$208K
QDEL icon
1358
QuidelOrtho
QDEL
$1.05B
– –
-5,974
Closed -$286K
RIGL icon
1359
Rigel Pharmaceuticals
RIGL
$875M
– –
-1,012
Closed -$15K
RKT icon
1360
Rocket Companies
RKT
$40.3B
– –
-11,332
Closed -$165K
RPD icon
1361
Rapid7
RPD
$910M
– –
-4,515
Closed -$221K
RUSHA icon
1362
Rush Enterprises Class A
RUSHA
$8.3B
– –
-4,022
Closed -$215K
SPCE icon
1363
Virgin Galactic
SPCE
$455M
– –
-1,070
Closed -$31.7K
SWTX
1364
DELISTED
SpringWorks Therapeutics
SWTX
– –
-4,164
Closed -$205K
VCEL icon
1365
Vericel Corp
VCEL
$2.11B
– –
-4,848
Closed -$252K
VIG icon
1366
Vanguard Dividend Appreciation ETF
VIG
$113B
– –
-11,650
Closed -$2.13M
W icon
1367
Wayfair
W
$14.4B
– –
-5,765
Closed -$391K
WDFC icon
1368
WD-40
WDFC
$2.94B
– –
-821
Closed -$208K
WERN icon
1369
Werner Enterprises
WERN
$2.31B
– –
-9,121
Closed -$357K
WKHS icon
1370
Workhorse Group
WKHS
$34.6M
– –
-4
Closed -$2.74K
XSW icon
1371
State Street SPDR S&P Software & Services ETF
XSW
$534M
– –
-1,292
Closed -$202K
JBTM
1372
JBT Marel
JBTM
$6.12B
– –
-1,931
Closed -$203K
CTEV
1373
Claritev Corp
CTEV
$657M
– –
-566
Closed -$18.4K
DM
1374
DELISTED
Desktop Metal, Inc.
DM
– –
-1,636
Closed -$14.4K
NKLA
1375
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-1,483
Closed -$46.3K
52 53 54
55
56

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.